Inhibitor Therapeutics Statistics
Total Valuation
INTI has a market cap or net worth of $15.51 million. The enterprise value is $7.83 million.
| Market Cap | 15.51M |
| Enterprise Value | 7.83M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
INTI has 172.32 million shares outstanding. The number of shares has increased by 0.17% in one year.
| Shares Outstanding | 172.32M |
| Shares Change (YoY) | +0.17% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 58.48% |
| Owned by Institutions (%) | n/a |
| Float | 75.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.34 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 50.01, with zero debt.
| Current Ratio | 50.01 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -68.37% and return on invested capital (ROIC) is -76.54%.
| Return on Equity (ROE) | -68.37% |
| Return on Assets (ROA) | -40.69% |
| Return on Capital (ROIC) | -76.54% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.06M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -776,090 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +162.39% in the last 52 weeks. The beta is -0.66, so INTI's price volatility has been lower than the market average.
| Beta (5Y) | -0.66 |
| 52-Week Price Change | +162.39% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.08 |
| Relative Strength Index (RSI) | 46.68 |
| Average Volume (20 Days) | 475 |
Short Selling Information
The latest short interest is 19,880, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 19,880 |
| Short Previous Month | 40 |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.03% |
| Short Ratio (days to cover) | 0.08 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.55M |
| Pretax Income | -3.17M |
| Net Income | -3.17M |
| EBITDA | -3.37M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -$0.02 |
Balance Sheet
The company has $7.68 million in cash and no debt, giving a net cash position of $7.68 million or $0.04 per share.
| Cash & Cash Equivalents | 7.68M |
| Total Debt | n/a |
| Net Cash | 7.68M |
| Net Cash Per Share | $0.04 |
| Equity (Book Value) | 4.64M |
| Book Value Per Share | 0.03 |
| Working Capital | 7.64M |
Cash Flow
| Operating Cash Flow | -3.10M |
| Capital Expenditures | n/a |
| Free Cash Flow | -3.10M |
| FCF Per Share | -$0.02 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.17% |
| Shareholder Yield | -0.17% |
| Earnings Yield | -20.45% |
| FCF Yield | -20.00% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |